Loading cancer entity…
Loading cancer entity…
Clinical trials
91 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06690281 | A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Sep 11, 2025 | clinicaltrials |
| NCT01913275 | Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy | withdrawn | N/A | 0 | All India Institute of Medical SciencesOTHER | 1 | Jan 31, 2024 |
| clinicaltrials |
| NCT02446379 | Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery(CLIO) | withdrawn | — | 0 | Lightpoint Medical LimitedINDUSTRY | 1 | Jan 26, 2017 | clinicaltrials |
| NCT00487851 | Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer | withdrawn | Phase 2 | 0 | Karolinska InstitutetOTHER | 1 | Apr 12, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Sep 11, 2025source: clinicaltrials